Echocardiographic patterns in treatment-naïve HIV-positive patients in Lagos, south-west Nigeria.

PubWeight™: 0.78‹?›

🔗 View Article (PMC 3734877)

Published in Cardiovasc J Afr on July 30, 2012

Authors

D A Olusegun-Joseph1, J N A Ajuluchukwu, C C Okany, A C Mbakwem, D A Oke, N U Okubadejo

Author Affiliations

1: Department of Cardiology, Lagos University Teaching Hospital, Lagos, Nigeria. danielsangrt@gmail.com

Articles cited by this

Recommendations for chamber quantification. Eur J Echocardiogr (2006) 11.39

Retracted Incidence of dilated cardiomyopathy and detection of HIV in myocardial cells of HIV-positive patients. Gruppo Italiano per lo Studio Cardiologico dei Pazienti Affetti da AIDS. N Engl J Med (1998) 4.93

American Society of Echocardiography recommendations for use of echocardiography in clinical trials. J Am Soc Echocardiogr (2004) 4.88

Report of the American Society of Echocardiography Committee on Nomenclature and Standards in Two-dimensional Echocardiography. Circulation (1980) 3.87

Pericardial effusion in AIDS. Incidence and survival. Circulation (1995) 3.22

Pericardial disease and human immunodeficiency virus in Dar es Salaam, Tanzania. Lancet (1990) 2.00

Cardiac manifestations of acquired immunodeficiency syndrome. Arch Intern Med (2000) 1.79

Clinical profile of HIV-related aneurysms. Eur J Vasc Endovasc Surg (2000) 1.65

Unsuspected cardiac abnormalities in the acquired immune deficiency syndrome. An echocardiographic study. Chest (1989) 1.48

Cardiomyopathy associated with antiretroviral therapy in patients with HIV infection: a report of six cases. Ann Intern Med (1992) 1.46

Cardiac manifestations of human immunodeficiency virus infection: a two-dimensional echocardiographic study. J Am Coll Cardiol (1989) 1.40

Dilated cardiomyopathy in HIV-infected patients. N Engl J Med (1998) 1.37

Heart muscle disease related to HIV infection: prognostic implications. BMJ (1994) 1.37

Large artery vasculopathy in HIV-positive patients: another vasculitic enigma. Hum Pathol (2000) 1.33

Impact of human immunodeficiency virus infection on cardiovascular disease in Africa. Circulation (2005) 1.29

Cardiovascular manifestations of HIV infection. J R Soc Med (2001) 1.27

Heart involvement and HIV infection in African patients: determinants of survival. Int J Cardiol (1998) 1.11

Echocardiography detects myocardial damage in AIDS: prospective study in 102 patients. Eur Heart J (1988) 1.08

Congestive cardiomyopathy and illness related to the acquired immunodeficiency syndrome (AIDS) associated with isolation of retrovirus from myocardium. Ann Intern Med (1987) 1.06

Reversibility of cardiac abnormalities in human immunodeficiency virus (HIV)-infected individuals: a serial echocardiographic study. J Am Coll Cardiol (1991) 1.06

Assessment of ventricular diastolic function in AIDS patients from Congo: a Doppler echocardiographic study. Heart (1998) 1.02

Prevalence and incidence of left ventricular dysfunction in patients with human immunodeficiency virus infection. Am J Cardiol (1993) 1.00

Cardiac autoimmunity in HIV related heart muscle disease. Heart (1998) 1.00

Rapid evolution of cardiac tamponade due to bacterial pericarditis in two patients with HIV-1 infection. Chest (1992) 0.94

Dilated cardiomyopathy in HIV-infected patients. N Engl J Med (1999) 0.94

Cardiac involvement in acquired immunodeficiency syndrome--a review to push action. The Committee for the Study of Cardiac Involvement in AIDS. Clin Cardiol (1998) 0.91

Cardiac involvement in HIV infected people in Yaounde, Cameroon. Postgrad Med J (2002) 0.91

Myocardial dysfunction in human immunodeficiency virus infection: an echocardiographic study of 157 patients in hospital in Zimbabwe. Heart (1996) 0.90

Cardiac manifestations of HIV/AIDS: a review of disease spectrum and clinical management. J Acquir Immune Defic Syndr Hum Retrovirol (1998) 0.89

Early impairment of systolic and diastolic function in asymptomatic HIV-positive patients: a multicenter echocardiographic and echo-Doppler study. The Gruppo Italiano Per lo Studio Cardiologico dei Pazienti Affetti da AIDS. AIDS Res Hum Retroviruses (1996) 0.87

HIV and cardiovascular medicine. Heart (2003) 0.87

Pericardial involvement in human immunodeficiency virus infection. Chest (1999) 0.86

Intensity of myocardial expression of inducible nitric oxide synthase influences the clinical course of human immunodeficiency virus-associated cardiomyopathy. Gruppo Italiano per lo Studio Cardiologico dei pazienti affetti da AIDS (GISCA). Circulation (1999) 0.85

Cardiac morbidity in the human immunodeficiency virus infection. Rev Port Cardiol (1994) 0.84

Dilated heart muscle disease associated with HIV infection. Eur Heart J (1995) 0.83

Emerging patterns of heart disease in HIV infected homosexual subjects with and without opportunistic infections; a prospective colour flow Doppler echocardiographic study. Eur Heart J (1994) 0.82

The expanding role of the cardiologist in the care of HIV infected patients. Heart (2001) 0.82

Epidemiology and pathogenesis of human immunodeficiency virus (HIV) related heart disease: a review. Niger J Med (2005) 0.79

Left ventricular dysfunction in human immunodeficiency virus (HIV)-infected patients. Int J Cardiol (1998) 0.78

Cryptococcal pericarditis in an intravenous drug abuser. J Infect Dis (1985) 0.78

Fatal pericarditis due to Mycobacterium avium-intracellulare in acquired immunodeficiency syndrome. Chest (1989) 0.77

Doppler echocardiographic evaluation of HIV-positive patients in different stages of the disease. Arq Bras Cardiol (1999) 0.76

Articles by these authors

Pernicious anaemia in Africans. Clin Lab Haematol (1992) 1.40

Prevalence of abnormal cervical smears among patients with HIV in Lagos, Nigeria. West Afr J Med (2007) 1.15

Prevalence and clinical characteristics of headache in medical students of the University of Lagos, Nigeria. Cephalalgia (2009) 1.08

Absolute lymphocyte count as surrogate for CD4+ cell count in monitoring response to antiretroviral therapy. Niger Postgrad Med J (2001) 1.01

Spectrum of clinical diseases in HIV-infected adults at the Lagos University Teaching Hospital: a five-year experience [1992-1996]. Afr J Med Med Sci (1999) 0.93

Bradypacing: indications and management challenges in Nigeria. Pacing Clin Electrophysiol (2007) 0.92

Seroprevalence study of HTLV-1 and HIV infection in blood donors and patients with lymphoid malignancies in Lagos, Nigeria. Cent Afr J Med (1998) 0.92

Pattern of dyslipidaemia among Nigerians with type 2 diabetes mellitus. Niger J Clin Pract (2008) 0.92

Factors influencing non-compliance with anti-hypertensive drug therapy in Nigerians. Niger Postgrad Med J (2007) 0.89

Evaluation of saliva-based diagnostic test kit for routine detection of antibodies to HIV. Afr J Med Med Sci (2001) 0.85

Evaluation of a rapid test kit for detection of HBsAg/eAg in whole blood: a possible method for pre-donation testing. Afr J Med Med Sci (2006) 0.84

Antihypertensive pharmacotherapy in a developing economy: pattern, acquisition costs and conformity to international guidelines in a tertiary-care setting. J Hum Hypertens (2006) 0.84

Evaluation of haemodynamic changes in hypertensive patients during tooth extraction under local anaesthesia. West Indian Med J (2011) 0.83

Effects of ethanol on cell volume and protein synthesis in a human lymphoblastoid cell line (Raji). Acta Haematol (1983) 0.82

Relationship between admission serum C-reactive protein and short term outcome following acute ischaemic stroke at a tertiary health institution in Nigeria. Niger J Clin Pract (2013) 0.82

Psychiatric morbidity in hypertensives attending a cardiology outpatient clinic in West Africa. Niger J Clin Pract (2012) 0.81

Achieving blood preSsure goals sTudy in uncontrolled hypeRtensive pAtients treated with a fixed-dose combination of ramipriL/hydrochlorothiazide: the ASTRAL study. Cardiovasc J Afr (2011) 0.80

Efficacy of endoscopic third ventriculostomy in the management of hydrocephalus in children under 2 years of age: experience from a tertiary institution in Nigeria. Niger J Clin Pract (2015) 0.78

QT dispersion in hypertensive Nigerians with and without left ventricular hypertrophy. West Afr J Med (2013) 0.77

Hypofibronectinaemia and severity of sickle cell anaemia in Nigeria. Br J Haematol (2000) 0.77

Trends in acute emergency room hypertension related deaths: an autopsy study. Niger J Clin Pract (2009) 0.77

Effect of cervical traction on cardiovascular and selected ECG variables of cervical spondylosis patients using various weights. Niger Postgrad Med J (2006) 0.77

A preliminary study of the frequency of focal neurological deficits in HIV/AIDS patients seropositive for Toxoplasma gondii IgG in Lagos, Nigeria. Nig Q J Hosp Med (2010) 0.77

Magnitude and gender distribution of obesity and abdominal adiposity in Nigerians with type 2 diabetes mellitus. Niger J Clin Pract (2007) 0.76

Comparative study of the effect of tocotrienols and -tocopherol on fasting serum lipid profiles in patients with mild hypercholesterolaemia: a preliminary report. Niger Postgrad Med J (2007) 0.75

Prevalence of Campylobacter species among HIV/AIDS patients in Nigeria. Br J Biomed Sci (2002) 0.75

Clinical usefulness of a timed overnight (8 hours) Urine Albumin (microalbumin) excretion in monitor-ing treatment in benign essential hypertension. Niger Postgrad Med J (2014) 0.75

Marfan syndrome: a study of a Nigerian family and review of current cardiovascular management. West Afr J Med (2009) 0.75

Factory floor injury in a Lagos sawmill. West Afr J Med (2002) 0.75

Plasma homocysteine level and its relationship to clinical profile in Parkinson's disease patients at the Lagos University Teaching Hospital. West Afr J Med (2012) 0.75

Sexual dysfunction among subjects with hypertension in a Nigerian teaching hospital. Nig Q J Hosp Med (2011) 0.75

QT Dispersion in Healthy Adult Nigerians. Nig Q J Hosp Med (2016) 0.75

Perception of Nigerian internal medicine residents on the diagnosis and management of heart failure. Niger Postgrad Med J (2007) 0.75

A randomised trial to compare the efficacy and safety of Felodipine (Plendil) and Nifedipine (Adalat) retard in patients with mild-to-moderate hypertension. West Afr J Med (2002) 0.75